Venture Europe: Entrepreneurship | Technology | Venture Capital | Eu/Acc

Florian Brand - MDMA and DMT trials, Raising $400M from Peter Thiel and other investors, Difficulties of bringing a drug to market, The journey of increasing self-awareness


Listen Later

Florian Brand co-founder and Co-CEO of ATAI Life Sciences.

ATAI was founded in 2018 and is a global, listed, biopharma company with the vision to heal mental health disorders so that everyone, everywhere can live a more fulfilled life.

They were one of the pioneers to use psilocybin in treating mental health and they have raised around $400M equity and debt from Petter Thiel and other investors to build a portfolio of compounds like MDMA, DMT and others, to go through clinical trials and bring them to market.

During this episode we discuss about Florians' motivation to start Atai, how drug discovery works and why it takes around 10 years to bring to market, and a personal story of trying psychedelics to go through the loss of a loved one.

Enjoy!

...more
View all episodesView all episodes
Download on the App Store

Venture Europe: Entrepreneurship | Technology | Venture Capital | Eu/AccBy Calin Fabri | Entrepreneur | Advisor


More shows like Venture Europe: Entrepreneurship | Technology | Venture Capital | Eu/Acc

View all
The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch by Harry Stebbings

The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch

527 Listeners

The Daily by The New York Times

The Daily

112,467 Listeners

Wild Business Growth by Max Branstetter

Wild Business Growth

176 Listeners

All-In with Chamath, Jason, Sacks & Friedberg by All-In Podcast, LLC

All-In with Chamath, Jason, Sacks & Friedberg

9,806 Listeners

Huberman Lab by Scicomm Media

Huberman Lab

29,206 Listeners

Unsupervised Learning by by Redpoint Ventures

Unsupervised Learning

51 Listeners